Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69426 - 69450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	ANXA10	11199	upregulated	Silicon Dioxide analog results in increased expression of ANXA10 mRNA	4q32.3	A24195
Silicon dioxide	Approved	ANXA13	312	downregulated	Silicon Dioxide analog results in decreased expression of ANXA13 mRNA	8q24.13	A24195
Silicon dioxide	Approved	ANXA2P3	305	upregulated	Silicon Dioxide results in increased expression of ANXA2P3 mRNA	10q21.3	A24196
Silicon dioxide	Approved	ANXA3	306	upregulated	Silicon Dioxide analog results in increased expression of ANXA3 mRNA	4q21.21	A24195
Silicon dioxide	Approved	ANXA4	307	downregulated	Silicon Dioxide analog results in decreased expression of ANXA4 mRNA	2p13.3	A24195
Silicon dioxide	Approved	ANXA6	309	upregulated	Silicon Dioxide results in increased expression of ANXA6 mRNA	5q33.1	A24196
Silicon dioxide	Approved	ANXA7	310	downregulated	Silicon Dioxide analog results in decreased expression of ANXA7 mRNA	10q22.2	A24194
Silicon dioxide	Approved	ANXA9	8416	downregulated	Silicon Dioxide analog results in decreased expression of ANXA9 mRNA	1q21.3	A24195
Silicon dioxide	Approved	AOC2	314	upregulated	Silicon Dioxide results in increased expression of AOC2 mRNA	17q21.31	A24196
Silicon dioxide	Approved	AOC3	8639	upregulated	Silicon Dioxide analog results in increased expression of AOC3 mRNA	17q21.31	A24194
Silicon dioxide	Approved	AOC3	8639	upregulated	Silicon Dioxide results in increased expression of AOC3 mRNA	17q21.31	A24196
Silicon dioxide	Approved	AOX1	316	downregulated	Silicon Dioxide analog results in decreased expression of AOX1 mRNA	2q33.1	A24194
Silicon dioxide	Approved	AOX1	316	upregulated	Silicon Dioxide analog results in increased expression of AOX1 mRNA	2q33.1	A24195
Silicon dioxide	Approved	AOX1	316	upregulated	Silicon Dioxide results in increased expression of AOX1 mRNA	2q33.1	A24196
Silicon dioxide	Approved	AP1S2	8905	upregulated	Silicon Dioxide analog results in increased expression of AP1S2 mRNA	Xp22.2	A24195
Silicon dioxide	Approved	AP2A1	160	downregulated	Silicon Dioxide analog results in decreased expression of AP2A1 mRNA	19q13.33	A24195
Silicon dioxide	Approved	AP4S1	11154	upregulated	Silicon Dioxide analog results in increased expression of AP4S1 mRNA	14q12	A24195
Silicon dioxide	Approved	APBB2	323	downregulated	Silicon Dioxide results in decreased expression of APBB2 mRNA	4p14-p13	A24196
Silicon dioxide	Approved	APCDD1L	164284	upregulated	Silicon Dioxide analog results in increased expression of APCDD1L mRNA	20q13.32	A24194
Silicon dioxide	Approved	APEX1	328	downregulated	Silicon Dioxide results in decreased expression of APEX1 mRNA	14q11.2	A24196
Silicon dioxide	Approved	APH1B	83464	downregulated	Silicon Dioxide analog results in decreased expression of APH1B mRNA	15q22.2	A24195
Silicon dioxide	Approved	APLN	8862	upregulated	Silicon Dioxide analog results in increased expression of APLN mRNA	Xq26.1	A24195
Silicon dioxide	Approved	APLP1	333	downregulated	Silicon Dioxide analog results in decreased expression of APLP1 mRNA	19q13.12	A24195
Silicon dioxide	Approved	APOBEC3A	200315	upregulated	Silicon Dioxide results in increased expression of APOBEC3A mRNA	22q13.1	A24196
Silicon dioxide	Approved	APOBEC3B	9582	upregulated	Silicon Dioxide results in increased expression of APOBEC3B mRNA	22q13.1	A24196

Displaying entries 69426 - 69450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability